Q: What are the Open Access Journals are available in your Publishing group?
Ans: Please visit the mentioned link [email protected] to view the list of Journals that are available with us.
Q: How can I submit my paper?
The candidate can submit Manuscript in email to [email protected] or submit from the Journal Web page
Q: What is the time required to publish my paper?
Ans: The peer process will take a minimum of 30 business days. After peer revise process, it will be published within 3 days after acceptance of the paper.
Q: How can I join as Reviewer to this Journal?
Ans: You can write your interest in email to [email protected] and we will get back to you in 3-4 days.
Q: Do Editor have to work continuously?
Ans: No, the editorial office will be helping you whenever required as we understand that you may be busy in other commitments.
Q: Whom do I have to contact at the Editorial office if I have any queries?
Ans: Kindly email your query to [email protected]. Editorial office or the respective Journal Managing Editor will respond you in 3-4 days.
Q: What is the eligibility if I would like to review a manuscript?
Ans: The reviewers are assigned by the Editors as per the research matching to the topic of manuscript. Self registered peer reviewers must be having a few published papers in the field of interest they mentioned.
Q: Do you charge for a manuscript submission?
Ans: There are no charges for manuscript submission. The authors only need to pay the article processing charges once the article is accepted.
Q: Is there any limit to review papers?
Ans: No. You may review as many manuscripts you wish according to manuscript topic match your interest.
Q: Why should an author pay the article processing charge?
In Open Access mode of publication, the scholarly literature will be made available to the researchers free of cost without any subscription charges. The whole maintenance of the operations i.e production of full text and PDF formats as well as archiving and indexing the published articles permanently through the article processing charges only. However, fee discounts will be provided to the authors from low income countries (According to World Bank classification).
Published : 20th May 2023
Authors : Yohannis Yilma*, Metasebia Getachew, Asrat Fenta, Yordanos Mezemir
Citation : Yilma Y, et al. (2023). Assessment of Undernutrition and Its Influencing Factors among Prisoners Living with HIV/AIDS in North Shoa Zone Amhara Region Ethiopia, 2022. Mathews J HIV AIDS. 6(1):23.
Published : 03rd April 2021
Authors : S.Tshimanga1*, A. Fouad1, K. Fakiri1, N. Rada1, G. Draiss1, N. Soraa2, B. Admou3, M. Bouskraoui1
Citation : S Tshimanga, A Fouad, K Fakiri, N Rada, G Draiss, N Soraa, et al. (2021). Secondary Bronchiectasis due to HIV Infection in Children. Mathews J HIV AIDS. 5(1):21.
Published : 25th September 2019
Authors : Olorunfemi Stephen
Citation : Stephen O. (2019). HIV Drugs Resistance - A Possible Consequence of Massive Anti-Retroviral Roll Out in Developing Countries - an Urgent Call For 1
Proper Monitoring (Part 1). Mathews J HIV AIDS 4(1): 20.
Published : 12th November 2018
Authors : Paulo Pereira1*, Sandra Xavier2
Citation : Pereira P and Xavier S. (2018). Computation of the Diagnostic Uncertainty as an Alternative to the Determination of Measurement Uncertainty for HIV Qualitative Binary Results. Mathews J HIV AIDS 3(1): 019
Published : 23rd July 2018
Authors : Berry Ikolango Bongenya1*, Ramazani Nemwanjare Bukongo1 , Ben Ilunga Bulanda1, Divine chuga1, Jean Yves Debels Kabasele1, Medard Omakoy Okonda1, Christian Tshisumbu1, Erick Ntambwe kamangu*1,2
Citation : Kamangu EN, Bongenya BI, Bukongo RN, Bulanda BI, et al. (2018). Gender Difference in Early Treatment Patients for Human Immunodeficiency Virus Type 1 Infection in Kinshasa, Democratic Republic of Congo.Mathews J HIV AIDS. 3(1): 018
Published : 05th January 2018
Authors : Callist L. Chomboko1*, Rogatus M. Kabyemera2 , Benson R. Kidenya3, Erasmus Kamugisha 3*
Citation : Kamugisha E, Chomboko CL, Kabyemera RM, and Kidenya BR. (2018). Prevalence and Predictors of Immunological Treatment Failure among HIV Infected Adults on the First-line Antiretroviral Therapy in Mbeya Region, Tanzania. Mathews J HIV AIDS. 3(1): 017